01/22/2024
Following the acquisition of ZEUS Scientific by Sebia in October 2022, we are delighted to inform you that as of January 1, 2024, ZEUS Scientific is operating as:
Sebia Autoimmune & Infectious Diseases
1️⃣ What will change regarding the products?
ZEUS Scientific will remain the legal manufacturer of products manufactured at its Branchburg, NJ site.
2️⃣ What about my contractual documents, invoices, etc.?
ZEUS Scientific will remain the legal entity, and there will be no changes to your contract, purchase orders, invoices, and other documents.
3️⃣ What products will be offered by Sebia Autoimmune & Infectious Diseases?
We will be offering products manufactured by Zeus (IFA, EIA, AtheNA), and other Sebia autoimmune and infectious diseases products, such as the Alegria 2 system and its associated reagents, once FDA-cleared.
Sebia Autoimmune & Infectious Diseases offers an expanded catalog of in vitro diagnostic products and services, specializing in several technologies and clinical areas, including inflammatory rheumatic diseases, serological detection of autoimmune vasculitis, thyroid diagnostics, gastroenterology and a number of infectious diseases, including industry-first superior solutions for Lyme disease testing.
👉 Follow our new page! www.linkedin.com/company/sebia-ai-id/
For questions, please contact us through our website www.zeusscientific.com.